Biocon bets big on new class of weight-loss drugs

Biocon bets big on new class of weight-loss drugs Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent

from Moneycontrol Business News https://ift.tt/SE7pAR6

No comments:

Post a Comment

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...